Search results for "Inventio"

showing 10 items of 13031 documents

Detection of human papillomavirus DNA in formalin-fixed, paraffin-embedded squamous papillomas of the oral cavity

2018

Background Squamous papillomas are exophytic proliferations of surface oral epithelium. Human papillomavirus (HPV) infection is widely accepted as the etiology of squamous papillomas however the virus cannot be detected in a significant percentage of lesions. Material and methods Using polymerase chain reaction (PCR), we tested 35 formalin-fixed paraffin-embedded (FFPE) squamous papillomas for the presence of HPV DNA. Results Six papillomas (17%) tested positive for HPV DNA; four contained HPV-6 and two contained HPV-11. Given that β-globin DNA was only identified in half of the samples, DNA degradation appears to have significantly impacted the results. Conclusions The results likely repre…

0301 basic medicinePathologymedicine.medical_specialtyFormalin fixed paraffin embeddedOral cavityViruslaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicinelawHuman papillomavirus DNAmedicineGeneral DentistryPolymerase chain reactionOral Medicine and Pathologybusiness.industryResearchHPV infectionvirus diseases:CIENCIAS MÉDICAS [UNESCO]medicine.diseasefemale genital diseases and pregnancy complications030104 developmental biologychemistry030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASPapillomabusinessDNAJournal of Clinical and Experimental Dentistry
researchProduct

Kupffer Cell and Monocyte-Derived Macrophage Identification by Immunofluorescence on Formalin-Fixed, Paraffin-Embedded (FFPE) Mouse Liver Sections

2020

Kupffer cells are the liver-resident macrophages and represent the first line of defense between the pathogens circulating from the intestines through the portal vein and systemic circulation. Recent works have highlighted the complex heterogeneity of macrophage functions and origins, thus raising awareness on the need for a better characterization of macrophage populations. The immunohistochemistry method here described, allows for a rapid distinction between Kupffer cells and monocyte-derived macrophages present on formalin-fixed, paraffin-embedded mouse liver samples. This protocol has been optimized for its reproducibility, reliability, and simplicity.

0301 basic medicinePathologymedicine.medical_specialtymedicine.diagnostic_testFormalin fixed paraffin embeddedMonocyte derivedChemistryMonocyteKupffer cellImmunofluorescencelaw.invention03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structureConfocal microscopylaw030220 oncology & carcinogenesismedicineMacrophageImmunohistochemistry
researchProduct

Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

2019

Introduction: Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease characterized by a severe deficiency of the enzymatic activity of ADAMTS13 caused by autoantibodies, with an incidence of 3-4 x106inhabitants per year according to the few published data available. Accurate estimates of the incidence of aTTP are important to assess the resources required for current treatments and to anticipate the need to develop new treatments. The aim of this study was to determine the actualincidence of aTTP in Spain, as well as its diagnosis, management, and associated complications. Material and methods:A cross-sectional surveywascarried out among hematologists working in Spanish hospi…

0301 basic medicinePediatricsmedicine.medical_specialtyExacerbationImmunologyPopulationThrombotic thrombocytopenic purpuraBiochemistrylaw.invention03 medical and health sciences0302 clinical medicineInterquartile rangelawmedicineeducationeducation.field_of_studybusiness.industryIncidence (epidemiology)Mortality rateCell BiologyHematologymedicine.diseaseIntensive care unit030104 developmental biologyRituximabbusiness030215 immunologymedicine.drugBlood
researchProduct

Effect of dietary interventions during weaning period on parental practice and lipoproteins and vitamin D status in two-year-old children

2016

ABSTRACT Objective: Evaluate if a two-day course for parents on nutrition and applied baby food preparation had an effect on child’s intake of home-made foods, lipid concentration, and vitamin D status. Design: Randomized controlled trial at age 6 months and follow-up at ages 15 and 24 months. Setting: Four health care clinics in Kristiansand, Norway. Subjects: Thirty-nine pairs of 6-month-old children and their parents in the intervention group and 20 pairs in the control group. Results: At age 15 months, the intervention group had lower intakes of ready-made porridge (2.0 vs. 5.8 servings per week (p < 0.05)), lower intake of canned baby food (2.9 vs. 6.3 servings per week (p < 0.05)) and…

0301 basic medicinePediatricsmedicine.medical_specialtyIntervention groupfeeding practicesArticlelaw.inventionBaby food03 medical and health sciencesDietary interventionschemistry.chemical_compoundRandomized controlled triallawCooking classesVitamin D and neurologyMedicineWeaningtoddlers030109 nutrition & dieteticsNutrition and Dieteticsbusiness.industryCholesterolCanned baby foodPublic Health Environmental and Occupational HealthlipoproteinschemistrybusinessdietFood Science
researchProduct

Does Pasteurized Donor Human Milk Efficiently Protect Preterm Infants Against Oxidative Stress?

2019

International audience; Pasteurized donor human milk (DHM) is the preferred alternative for infant nutrition when own mother's milk (OMM) is unavailable. Whether DHM is an efficient means for protecting preterm infants from oxidative stress remains unknown. We quantified a panel of oxidative stress biomarkers in urine samples from preterm infants (≤32 weeks of gestation and a birth weight ≤1500 g) receiving ≥80% of feeding volume as either DHM or OMM. The noninvasive in vivo assessment of oxidative stress showed no statistically significant difference between both groups at the time when full enteral nutrition (150 mL/kg body weight) was achieved and until hospital discharge. In addition, t…

0301 basic medicinePhysiology[SDV]Life Sciences [q-bio]Clinical BiochemistryPasteurizationmedicine.disease_causeBiochemistrylaw.inventionpreterm infant03 medical and health sciencesEnteral Nutritionfluids and secretionslawHumansMedicineoxidative stressLongitudinal StudiesProspective StudiesFood scienceMolecular BiologyGeneral Environmental Science2. Zero hungerMilk Human030102 biochemistry & molecular biologyfull enteral feedingbusiness.industryInfant Newbornfood and beveragesbiomarkersInfant nutritionCell BiologyInfant Low Birth Weight3. Good health030104 developmental biologydonor human milk (DHM)own mother's milk (OMM)PasteurizationGeneral Earth and Planetary SciencesFemalebusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionInfant PrematureOxidative stress
researchProduct

E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death

2018

International audience; E2F1 is the main pro-apoptotic effector of the pRB-regulated tumor suppressor pathway by promoting the transcription of various pro-apoptotic proteins. We report here that E2F1 partly localizes to mitochondria, where it favors mitochondrial outer membrane permeabilization. E2F1 interacts with BCL-xL independently from its BH3 binding interface and induces a stabilization of BCL-xL at mitochondrial membranes. This prevents efficient control of BCL-xL over its binding partners, in particular over BAK resulting in the induction of cell death. We thus identify a new, non-BH3-binding regulator of BCL-xL localization dynamics that influences its anti-apoptotic activity.

0301 basic medicineProgrammed cell deathTranscription Geneticbcl-X ProteinRegulatorBcl-xL[SDV.CAN]Life Sciences [q-bio]/CancerBCL-xL mobilityMitochondrionBiochemistrylaw.invention[ SDV.CAN ] Life Sciences [q-bio]/CancerE2F1 Subject Category Autophagy & Cell Death03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerlawBCL-2 familyCell Line TumorGeneticsJournal ArticleHumansE2F1Molecular BiologyCell DeathbiologyManchester Cancer Research CentreEffectorChemistryResearchInstitutes_Networks_Beacons/mcrcScientific ReportsapoptosisSubcellular localizationMitochondriaCell biologyProtein Transportbcl-2 Homologous Antagonist-Killer Protein030104 developmental biologyGene Expression RegulationProto-Oncogene Proteins c-bcl-2biology.proteinSuppressorbiological phenomena cell phenomena and immunityExtracellular SpaceE2F1 Transcription FactorProtein Binding
researchProduct

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (r…

2017

Autoimmune diseases are a complex set of diseases characterized by immune system activation and, although many progresses have been done in the last 15 years, several unmet needs in the management of these patients may be still identified. Recently, a panel of international Experts, divided in different working groups according to their clinical and scientific expertise, were asked to identify, debate and formulate a list of key unmet needs within the field of rheumatology, serving as a roadmap for research as well as support for clinicians. After a systematic review of the literature, the results and the discussions from each working group were summarised in different statements. Due to th…

0301 basic medicineQuality managementEffectivenesslaw.inventionSystemic sclerosi0302 clinical medicineAntiphospholipid syndrome; Biologic drugs treatment; Effectiveness; Remission; Rheumatoid arthritis; Sjogren's syndrome; Spondyloarthritides; Systemic lupus erythematosus; Systemic sclerosis; Unmet needs; Immunology and Allergy; ImmunologylawAntiphospholipid syndromeImmunology and AllergyDisease management (health)ComputingMilieux_MISCELLANEOUSSpondyloarthritideClinical Trials as TopicEffectiveneDisease ManagementQuality Improvement3. Good healthSjogren's syndromeRheumatoid arthritis[SDV.IMM]Life Sciences [q-bio]/ImmunologySystemic sclerosisUnmet needmedicine.medical_specialtyRemissionImmunologyAntiphospholipid syndrome; Biologic drugs treatment; Effectiveness; Remission; Rheumatoid arthritis; Sjogren's syndrome; Spondyloarthritides; Systemic lupus erythematosus; Systemic sclerosis; Unmet needs;Systemic lupus erythematosuUnmet needs; rheumatoid arthritis; spondyloarthritides;Unmet needsNOAutoimmune Diseases03 medical and health sciencesSystemic lupus erythematosusAntiphospholipid syndromeInternal medicineRheumatic DiseasesmedicineHumansRheumatoid arthritisIntensive care medicineRheumatoid arthriti030203 arthritis & rheumatologyAutoimmune diseasetherapybusiness.industryAntiphospholipid syndrome; Biologic drugs treatment; Effectiveness; Remission; Rheumatoid arthritis; Sjogren's syndrome; Spondyloarthritides; Systemic lupus erythematosus; Systemic sclerosis; Unmet needs; Autoimmune Diseases; Clinical Trials as Topic; Disease Management; Humans; Quality Improvement; Rheumatic Diseases; Immunology and Allergy; Immunologymedicine.diseaseRheumatologyBiologic drugs treatment030104 developmental biologyautoimmune rheumatic diseasesPhysical therapyCLARITYSpondyloarthritidesbusinessWorking group
researchProduct

Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain

2017

We describe and characterize an exceptionally large HIV-1 subtype B transmission cluster occurring in the Comunidad Valenciana (CV, Spain). A total of 1806 HIV-1 protease-reverse transcriptase (PR/RT) sequences from different patients were obtained in the CV between 2004 and 2014. After subtyping and generating a phylogenetic tree with additional HIV-1 subtype B sequences, a very large transmission cluster which included almost exclusively sequences from the CV was detected (n = 143 patients). This cluster was then validated and characterized with further maximum-likelihood phylogenetic analyses and Bayesian coalescent reconstructions. With these analyses, the CV cluster was delimited to 11…

0301 basic medicineRNA virusesMaleEpidemiologyLineage (evolution)lcsh:MedicineHIV InfectionsPathology and Laboratory MedicineMen who have sex with menCoalescent theorylaw.inventionGeographical LocationsDatabase and Informatics MethodsImmunodeficiency VirusesHIV ProteaselawMedicine and Health Scienceslcsh:ScienceValenciaPhylogenyMultidisciplinarybiologyPhylogenetic treePhylogenetic AnalysisHIV diagnosis and managementSubtypingHIV Reverse TranscriptaseVirusEuropeTransmission (mechanics)Medical MicrobiologyHIV epidemiologyViral PathogensVirusesFemalePathogensMalalties de transmissió sexualSequence AnalysisResearch ArticleBioinformaticsDisease clusterResearch and Analysis MethodsMicrobiology03 medical and health sciencesRetrovirusesDrug Resistance ViralHumansHomosexuality MaleMolecular Biology TechniquesMicrobial PathogensMolecular BiologyDemographyMolecular Biology Assays and Analysis Techniqueslcsh:RLentivirusOrganismsBiology and Life SciencesHIVbiology.organism_classificationDiagnostic medicine030104 developmental biologySpainpol Gene Products Human Immunodeficiency VirusPeople and PlacesHIV-1lcsh:QSequence AlignmentDemography
researchProduct

Cosavirus, Salivirus and Bufavirus in Diarrheal Tunisian Infants

2016

International audience; Three newly discovered viruses have been recently described in diarrheal patients: Cosa-virus (CosV) and Salivirus (SalV), two picornaviruses, and Bufavirus (BuV), a parvovirus. The detection rate and the role of these viruses remain to be established in acute gastroen-teritis (AGE) in diarrheal Tunisian infants. From October 2010 through March 2012, stool samples were collected from 203 children <5 years-old suffering from AGE and attending the Children's Hospital in Monastir, Tunisia. All samples were screened for CosV, SalV and BuV as well as for norovirus (NoV) and group A rotavirus (RVA) by molecular biology. Positive samples for the three screened viruses were …

0301 basic medicineRNA virusesMaleRotavirusViral DiseasesHuman astrovirusesIdentificationvirusesEnteric viruseslcsh:MedicinePolymerase chain-reactionArtificial Gene Amplification and ExtensionPicornaviridaemedicine.disease_causePathology and Laboratory MedicinePolymerase Chain ReactionPediatricsReverse-transcription-pcrlaw.inventionParvoviruslaw[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRotavirusMedicine and Health Scienceslcsh:ScienceChildrenPolymerase chain reactionPhylogenyMultidisciplinarybiologyTransmission (medicine)[ SDV.IDA ] Life Sciences [q-bio]/Food engineeringPhylogenetic Analysis3. Good healthGastroenteritisInfectious DiseasesMedical MicrobiologyViral PathogensChild PreschoolViruses[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemalePathogensAichi virusPediatric InfectionsResearch ArticleDiarrheaTunisia030106 microbiologyGastroenterology and HepatologyResearch and Analysis MethodsMicrobiologyCalicivirusesAstrovirus03 medical and health sciencesKlassevirusParvovirusesAdeno-Associated VirusesmedicineHumansMolecular Biology TechniquesMolecular BiologyMicrobial PathogensRotavirus InfectionMolecular Biology Assays and Analysis TechniquesParvovirusNoroviruslcsh:ROrganismsBiology and Life SciencesInfantSapovirusReverse Transcriptase-Polymerase Chain Reactionbiology.organism_classificationVirology030104 developmental biologyNoroviruslcsh:QDNA viruses
researchProduct

Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublis…

2018

Zofenopril is a lipophilic, sulfhydryl group-containing angiotensin-converting enzyme (ACE)-inhibitor, characterized by wide tissue distribution, long duration of action, and pleiotropic effects on endothelial dysfunction. Its clinical efficacy and safety have been described in the four randomized controlled trials of the SMILE program, which globally enrolled more than 3600 patients in post-acute myocardial infarction (AMI) setting. The SMILE-4 study specifically selected patients with left ventricular dysfunction at admission, and compared the effects of zofenopril or ramipril in combination with acetylsalicylic acid (ASA). Zofenopril demonstrated its superiority over ramipril in reducing…

0301 basic medicineRamiprilmedicine.medical_specialtyCaptoprilPopulationMyocardial InfarctionCardiologyAngiotensin-Converting Enzyme InhibitorsHeart failureReviewAcute myocardial infarction030204 cardiovascular system & hematologylaw.inventionZofenopril03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled trialDouble-Blind MethodRamiprillawInternal medicineAcute myocardial infarction; Angiotensin-converting enzyme inhibitors; Cardiology; Heart failure; Left ventricular dysfunction; Ramipril; Zofenopril; Pharmacology (medical)MedicineHumansPharmacology (medical)Myocardial infarctioneducationRandomized Controlled Trials as Topiceducation.field_of_studyLeft ventricular dysfunctionEjection fractionbusiness.industryGeneral Medicinemedicine.diseaseZofenopril030104 developmental biologyTreatment OutcomechemistryAngiotensin-converting enzyme inhibitorHeart failureCardiologyNumber needed to treatbusinessmedicine.drug
researchProduct